Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	transferase activity, transferring phosphorus-containing groups	TYK2 PIK3R4 FCSK FLT1 CRPPA OAS3 KDR TNKS FGFR4 LRRK1 PFKFB3 PRAG1 TRPT1	2.30e-05	938	71	13	GO:0016772
GeneOntologyMolecularFunction	phosphotransferase activity, alcohol group as acceptor	TYK2 PIK3R4 FCSK FLT1 KDR FGFR4 LRRK1 PFKFB3 PRAG1 TRPT1	1.95e-04	709	71	10	GO:0016773
GeneOntologyMolecularFunction	vascular endothelial growth factor receptor activity	FLT1 KDR	2.59e-04	7	71	2	GO:0005021
GeneOntologyMolecularFunction	heat shock protein binding	EEF1AKMT3 UNC45B APAF1 KDR NOD2	2.87e-04	163	71	5	GO:0031072
GeneOntologyMolecularFunction	Hsp90 protein binding	UNC45B KDR NOD2	9.90e-04	55	71	3	GO:0051879
GeneOntologyMolecularFunction	NAD+ nucleotidase, cyclic ADP-ribose generating	TLR2 SARM1	1.45e-03	16	71	2	GO:0061809
GeneOntologyMolecularFunction	kinase activity	TYK2 PIK3R4 FCSK FLT1 KDR FGFR4 LRRK1 PFKFB3 PRAG1	1.49e-03	764	71	9	GO:0016301
GeneOntologyMolecularFunction	transmembrane receptor protein tyrosine kinase activity	FLT1 KDR FGFR4	1.61e-03	65	71	3	GO:0004714
GeneOntologyMolecularFunction	protein tyrosine kinase activity	TYK2 FLT1 KDR FGFR4	1.78e-03	145	71	4	GO:0004713
GeneOntologyMolecularFunction	peptidoglycan binding	TLR2 NOD2	2.05e-03	19	71	2	GO:0042834
GeneOntologyMolecularFunction	transmembrane receptor protein kinase activity	FLT1 KDR FGFR4	3.45e-03	85	71	3	GO:0019199
Domain	PROTEIN_KINASE_TYR	TYK2 FLT1 KDR FGFR4 PRAG1	2.94e-05	97	69	5	PS00109
Domain	Tyr_kinase_AS	TYK2 FLT1 KDR FGFR4 PRAG1	2.94e-05	97	69	5	IPR008266
Domain	TyrKc	TYK2 FLT1 KDR FGFR4	3.15e-04	88	69	4	SM00219
Domain	Tyr_kinase_cat_dom	TYK2 FLT1 KDR FGFR4	3.15e-04	88	69	4	IPR020635
Domain	Tyr_kinase_rcpt_3_CS	FLT1 KDR	3.71e-04	8	69	2	IPR001824
Domain	RECEPTOR_TYR_KIN_III	FLT1 KDR	3.71e-04	8	69	2	PS00240
Domain	Ank_3	ASB18 TNKS	5.94e-04	10	69	2	PF13606
Domain	P-loop_NTPase	DNHD1 ABCC3 MYH3 MYH8 SPEF2 APAF1 SHPRH LRRK1 PFKFB3 NOD2	1.06e-03	848	69	10	IPR027417
Domain	Pkinase_Tyr	TYK2 FLT1 KDR FGFR4	1.33e-03	129	69	4	PF07714
Domain	Myosin_N	MYH3 MYH8	1.37e-03	15	69	2	PF02736
Domain	Myosin_N	MYH3 MYH8	1.37e-03	15	69	2	IPR004009
Domain	-	MON2 PIK3R4 UNC45B SARM1 CUL9	1.37e-03	222	69	5	1.25.10.10
Domain	Ank	ASB18 KANK4 TNKS LRRK1 ANKRD55	1.55e-03	228	69	5	PF00023
Domain	ARM-type_fold	MON2 PIK3R4 THADA UNC45B SARM1 CUL9	1.57e-03	339	69	6	IPR016024
Domain	Ser-Thr/Tyr_kinase_cat_dom	TYK2 FLT1 KDR FGFR4	1.70e-03	138	69	4	IPR001245
Domain	Myosin_tail_1	MYH3 MYH8	1.98e-03	18	69	2	PF01576
Domain	Myosin_tail	MYH3 MYH8	1.98e-03	18	69	2	IPR002928
Domain	Prot_kinase_dom	TYK2 PIK3R4 FLT1 KDR FGFR4 LRRK1 PRAG1	2.15e-03	489	69	7	IPR000719
Domain	Myosin-like_IQ_dom	MYH3 MYH8	2.21e-03	19	69	2	IPR027401
Domain	-	MYH3 MYH8	2.21e-03	19	69	2	4.10.270.10
Domain	-	ASB18 KANK4 TNKS LRRK1 ANKRD55	2.23e-03	248	69	5	1.25.40.20
Domain	PROTEIN_KINASE_DOM	TYK2 PIK3R4 FLT1 KDR FGFR4 LRRK1 PRAG1	2.25e-03	493	69	7	PS50011
Domain	ANK	ASB18 KANK4 TNKS LRRK1 ANKRD55	2.35e-03	251	69	5	SM00248
Domain	ANK_REPEAT	ASB18 KANK4 TNKS LRRK1 ANKRD55	2.43e-03	253	69	5	PS50088
Domain	Ankyrin_rpt-contain_dom	ASB18 KANK4 TNKS LRRK1 ANKRD55	2.48e-03	254	69	5	IPR020683
Domain	ANK_REP_REGION	ASB18 KANK4 TNKS LRRK1 ANKRD55	2.48e-03	254	69	5	PS50297
Domain	TIR	TLR2 SARM1	2.70e-03	21	69	2	SM00255
Domain	Ankyrin_rpt	ASB18 KANK4 TNKS LRRK1 ANKRD55	2.83e-03	262	69	5	IPR002110
Domain	ARM-like	MON2 PIK3R4 UNC45B SARM1 CUL9	3.22e-03	270	69	5	IPR011989
Domain	-	TLR2 SARM1	3.24e-03	23	69	2	3.40.50.10140
Domain	WGR_domain	TNKS TRPT1	3.52e-03	24	69	2	IPR008893
Domain	TIR	TLR2 SARM1	3.52e-03	24	69	2	PS50104
Domain	Kinase-like_dom	TYK2 PIK3R4 FLT1 KDR FGFR4 LRRK1 PRAG1	3.80e-03	542	69	7	IPR011009
Domain	TIR_dom	TLR2 SARM1	3.82e-03	25	69	2	IPR000157
Domain	CARD	APAF1 NOD2	4.78e-03	28	69	2	PF00619
Domain	Galactose-bd-like	CUL9 UBOX5 F5	5.09e-03	94	69	3	IPR008979
Domain	CARD	APAF1 NOD2	5.84e-03	31	69	2	IPR001315
Domain	-	DNHD1 ABCC3 SPEF2 APAF1 SHPRH LRRK1 PFKFB3 NOD2	6.08e-03	746	69	8	3.40.50.300
Domain	CARD	APAF1 NOD2	6.60e-03	33	69	2	PS50209
Domain	PROTEIN_KINASE_ATP	TYK2 PIK3R4 FLT1 KDR FGFR4 LRRK1	6.93e-03	459	69	6	PS00107
Domain	Ank_2	ASB18 TNKS LRRK1 ANKRD55	8.24e-03	215	69	4	PF12796
Domain	Myosin_head_motor_dom	MYH3 MYH8	8.68e-03	38	69	2	IPR001609
Pubmed	Identification of novel protein kinases expressed in the myocardium of the developing mouse heart.	TYK2 FLT1 KDR FGFR4	7.98e-08	20	72	4	7893599
Pubmed	A dual-activity topoisomerase complex regulates mRNA translation and turnover.	MON2 TYK2 ABCC3 THADA SH3TC1 CUL9 ZFYVE26 LRRK1 TNRC6C PRAG1 SH2B2 ADCY9 NOD2	3.91e-07	1105	72	13	35748872
Pubmed	Fetal liver kinase 1 is a receptor for vascular endothelial growth factor and is selectively expressed in vascular endothelium.	FLT1 KDR	4.23e-06	2	72	2	8356051
Pubmed	Vascular endothelial growth factor and its receptors in normal human testicular tissue.	FLT1 KDR	4.23e-06	2	72	2	9256359
Pubmed	Expression of vascular endothelial growth factor receptors in the endometrium of septate uterus.	FLT1 KDR	4.23e-06	2	72	2	19200976
Pubmed	Production of VEGF receptor 1 and 2 mRNA and protein during endochondral bone repair is differential and healing phase specific.	FLT1 KDR	4.23e-06	2	72	2	20947709
Pubmed	NOD2 mediates anti-inflammatory signals induced by TLR2 ligands: implications for Crohn's disease.	TLR2 NOD2	4.23e-06	2	72	2	15214053
Pubmed	Ceramide upregulation causes pulmonary cell apoptosis and emphysema-like disease in mice.	FLT1 KDR	4.23e-06	2	72	2	15852018
Pubmed	VEGFR1 and VEGFR2 in lip carcinogenesis and its association with microvessel density.	FLT1 KDR	4.23e-06	2	72	2	25895461
Pubmed	Recognition of Borrelia burgdorferi by NOD2 is central for the induction of an inflammatory reaction.	TLR2 NOD2	4.23e-06	2	72	2	20441518
Pubmed	VEGFR1 and VEGFR2 in Alzheimer's Disease.	FLT1 KDR	4.23e-06	2	72	2	29226875
Pubmed	Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye.	FLT1 KDR	4.23e-06	2	72	2	21731737
Pubmed	Expression of VEGF receptors on endothelial cells in mouse skeletal muscle.	FLT1 KDR	4.23e-06	2	72	2	22984559
Pubmed	Differential expression of the two VEGF receptors flt and KDR in placenta and vascular endothelial cells.	FLT1 KDR	4.23e-06	2	72	2	8126087
Pubmed	Quantitative assessment and clinical relevance of VEGFRs-positive tumor cells in refractory brain tumors.	FLT1 KDR	4.23e-06	2	72	2	32088190
Pubmed	Expression of vascular endothelial growth factor receptors during male germ cell differentiation in the mouse.	FLT1 KDR	4.23e-06	2	72	2	12773425
Pubmed	VEGF receptor blockade markedly reduces retinal microglia/macrophage infiltration into laser-induced CNV.	FLT1 KDR	4.23e-06	2	72	2	23977149
Pubmed	Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation.	FLT1 KDR	4.23e-06	2	72	2	15611243
Pubmed	Bacterial peptidoglycan breaks down intestinal tolerance via mast cell activation: the role of TLR2 and NOD2.	TLR2 NOD2	4.23e-06	2	72	2	17563761
Pubmed	GPR126 protein regulates developmental and pathological angiogenesis through modulation of VEGFR2 receptor signaling.	KDR ADGRG6	4.23e-06	2	72	2	25217645
Pubmed	Inhibition of prostate cancer osteoblastic progression with VEGF121/rGel, a single agent targeting osteoblasts, osteoclasts, and tumor neovasculature.	FLT1 KDR	4.23e-06	2	72	2	21343372
Pubmed	Selected angiogenic cytokines in systemic lupus erythematosus patients.	FLT1 KDR	4.23e-06	2	72	2	19811263
Pubmed	Flt1 and Flk1 mediate regulation of intraocular pressure and their double heterozygosity causes the buphthalmia in mice.	FLT1 KDR	4.23e-06	2	72	2	22426483
Pubmed	VEGFR1 tyrosine kinase signaling promotes lymphangiogenesis as well as angiogenesis indirectly via macrophage recruitment.	FLT1 KDR	4.23e-06	2	72	2	18174461
Pubmed	The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.	FLT1 KDR	4.23e-06	2	72	2	19955220
Pubmed	Involvement of VEGFR-2 (kdr/flk-1) but not VEGFR-1 (flt-1) in VEGF-A and VEGF-C-induced tube formation by human microvascular endothelial cells in fibrin matrices in vitro.	FLT1 KDR	4.23e-06	2	72	2	11824379
Pubmed	Herbal compound farnesiferol C exerts antiangiogenic and antitumor activity and targets multiple aspects of VEGFR1 (Flt1) or VEGFR2 (Flk1) signaling cascades.	FLT1 KDR	4.23e-06	2	72	2	20103598
Pubmed	Quantitative real-time reverse transcription PCR study of the expression of vascular endothelial growth factor (VEGF) splice variants and VEGF receptors (VEGFR-1 and VEGFR-2) in non small cell lung cancer.	FLT1 KDR	4.23e-06	2	72	2	17599955
Pubmed	Vascular endothelial growth factor directly inhibits primitive neural stem cell survival but promotes definitive neural stem cell survival.	FLT1 KDR	4.23e-06	2	72	2	16793887
Pubmed	The soluble VEGF receptor 1 and 2 expression in cerebral spinal fluid as an indicator for leukemia central nervous system metastasis.	FLT1 KDR	4.23e-06	2	72	2	23400753
Pubmed	NOD2 and TLR2 ligands trigger the activation of basophils and eosinophils by interacting with dermal fibroblasts in atopic dermatitis-like skin inflammation.	TLR2 NOD2	4.23e-06	2	72	2	26388234
Pubmed	Butyrate mediates nucleotide-binding and oligomerisation domain (NOD) 2-dependent mucosal immune responses against peptidoglycan.	TLR2 NOD2	4.23e-06	2	72	2	19830732
Pubmed	Endothelial progenitor cells induce transplant arteriosclerosis via VEGFR-1/2 activity.	FLT1 KDR	4.23e-06	2	72	2	25437886
Pubmed	Invasive Streptococcus mutans induces inflammatory cytokine production in human aortic endothelial cells via regulation of intracellular toll-like receptor 2 and nucleotide-binding oligomerization domain 2.	TLR2 NOD2	4.23e-06	2	72	2	27004566
Pubmed	Nucleotide-binding oligomerization domain 2 and Toll-like receptor 2 function independently in a murine model of arthritis triggered by intraarticular peptidoglycan.	TLR2 NOD2	4.23e-06	2	72	2	20131263
Pubmed	Differential transcriptional regulation of the two vascular endothelial growth factor receptor genes. Flt-1, but not Flk-1/KDR, is up-regulated by hypoxia.	FLT1 KDR	4.23e-06	2	72	2	9295307
Pubmed	Trophoblast expression of fms-like tyrosine kinase 1 is not required for the establishment of the maternal-fetal interface in the mouse placenta.	FLT1 KDR	4.23e-06	2	72	2	14668430
Pubmed	Endothelial cell-by-cell profiling reveals the temporal dynamics of VEGFR1 and VEGFR2 membrane localization after murine hindlimb ischemia.	FLT1 KDR	4.23e-06	2	72	2	23376830
Pubmed	Expression of vascular endothelial growth factor receptor-1/-2 and nitric oxide in unruptured intracranial aneurysms.	FLT1 KDR	4.23e-06	2	72	2	20635108
Pubmed	Hypoxia differentially regulates VEGFR1 and VEGFR2 levels and alters intracellular signaling and cell migration in endothelial cells.	FLT1 KDR	4.23e-06	2	72	2	21168388
Pubmed	Distinct expression patterns of Flk1 and Flt1 in the coronary vascular system during development and after myocardial infarction.	FLT1 KDR	4.23e-06	2	72	2	29158084
Pubmed	Signaling via pattern recognition receptors NOD2 and TLR2 contributes to immunomodulatory control of lethal pneumovirus infection.	TLR2 NOD2	4.23e-06	2	72	2	27312104
Pubmed	Staphylococcal peptidoglycan co-localizes with Nod2 and TLR2 and activates innate immune response via both receptors in primary murine keratinocytes.	TLR2 NOD2	4.23e-06	2	72	2	20949035
Pubmed	Vascular endothelial growth factor-induced genes in human umbilical vein endothelial cells: relative roles of KDR and Flt-1 receptors.	FLT1 KDR	4.23e-06	2	72	2	12426207
Pubmed	Randomized Phase II Study of Ramucirumab or Icrucumab in Combination with Capecitabine in Patients with Previously Treated Locally Advanced or Metastatic Breast Cancer.	FLT1 KDR	4.23e-06	2	72	2	28220020
Pubmed	Comparative study of human colonic tumor-derived endothelial cells (HCTEC) and normal colonic microvascular endothelial cells (HCMEC): Hypoxia-induced sVEGFR-1 and sVEGFR-2 levels.	FLT1 KDR	4.23e-06	2	72	2	19287991
Pubmed	Immunohistochemical expression of vascular endothelial growth factor A (VEGF), and its receptors (VEGFR1, 2) in normal and pathologic conditions of the human thymus.	FLT1 KDR	4.23e-06	2	72	2	18356031
Pubmed	The role of heterodimerization between VEGFR-1 and VEGFR-2 in the regulation of endothelial cell homeostasis.	FLT1 KDR	4.23e-06	2	72	2	22828632
Pubmed	Suppression of migratory and metastatic pathways via blocking VEGFR1 and VEGFR2.	FLT1 KDR	4.23e-06	2	72	2	30929546
Pubmed	Proangiogenic Effect of Metformin in Endothelial Cells Is via Upregulation of VEGFR1/2 and Their Signaling under Hyperglycemia-Hypoxia.	FLT1 KDR	4.23e-06	2	72	2	29351188
Pubmed	Comparative structure-function analysis of VEGFR-1 and VEGFR-2: What have we learned from chimeric systems?	FLT1 KDR	4.23e-06	2	72	2	12814952
Pubmed	In vivo regulation of mRNA expression of vascular endothelial growth factor receptors (KDR and flt-1) in the human oviduct.	FLT1 KDR	4.23e-06	2	72	2	14967383
Pubmed	Blockade of VEGFR2 and not VEGFR1 can limit diet-induced fat tissue expansion: role of local versus bone marrow-derived endothelial cells.	FLT1 KDR	4.23e-06	2	72	2	19333381
Pubmed	Nod2 deficiency impairs inflammatory and epithelial aspects of the cutaneous wound-healing response.	TLR2 NOD2	4.23e-06	2	72	2	22951952
Pubmed	Hypoxia-induced reduction of sVEGFR-2 levels in human colonic microvascular endothelial cells in vitro: Comparative study with HUVEC.	FLT1 KDR	4.23e-06	2	72	2	19082506
Pubmed	VEGFR1 and VEGFR2 immunohistochemical expression in oral squamous cell carcinoma: a morphometric study.	FLT1 KDR	4.23e-06	2	72	2	22203933
Pubmed	Absence of mutations in the activation loop and juxtamembrane domains of VEGFR-1 and VEGFR-2 gene in chronic myelomonocytic leukemia (CMML).	FLT1 KDR	4.23e-06	2	72	2	22153185
Pubmed	Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.	FLT1 KDR	4.23e-06	2	72	2	18975312
Pubmed	Soluble forms of VEGF receptor-1 and -2 promote vascular maturation via mural cell recruitment.	FLT1 KDR	4.23e-06	2	72	2	20484670
Pubmed	The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching.	FLT1 KDR	4.23e-06	2	72	2	18504303
Pubmed	Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.	FLT1 KDR	4.23e-06	2	72	2	20158393
Pubmed	Nod2 suppresses Borrelia burgdorferi mediated murine Lyme arthritis and carditis through the induction of tolerance.	TLR2 NOD2	4.23e-06	2	72	2	21387014
Pubmed	Expression of vascular endothelial growth factor receptors is closely related to the histological grade of hepatocellular carcinoma.	FLT1 KDR	4.23e-06	2	72	2	16786116
Pubmed	A cyclic peptide reproducing the α1 helix of VEGF-B binds to VEGFR-1 and VEGFR-2 and inhibits angiogenesis and tumor growth.	FLT1 KDR	4.23e-06	2	72	2	30700502
Pubmed	Aberrant Expression of Bacterial Pattern Recognition Receptor NOD2 of Basophils and Microbicidal Peptides in Atopic Dermatitis.	TLR2 NOD2	4.23e-06	2	72	2	27077833
Pubmed	Bone formation during distraction osteogenesis is dependent on both VEGFR1 and VEGFR2 signaling.	FLT1 KDR	4.23e-06	2	72	2	18433297
Pubmed	The vascular endothelial growth factor (VEGF) receptor Flt-1 (VEGFR-1) modulates Flk-1 (VEGFR-2) signaling during blood vessel formation.	FLT1 KDR	4.23e-06	2	72	2	15111299
Pubmed	The crosstalk between TLR2 and NOD2 in Aspergillus fumigatus keratitis.	TLR2 NOD2	4.23e-06	2	72	2	25549945
Pubmed	Increased expression of KDR/Flk-1 (VEGFR-2) in murine model of ischemia-induced retinal neovascularization.	FLT1 KDR	4.23e-06	2	72	2	9828156
Pubmed	Bovine papular stomatitis virus encodes a functionally distinct VEGF that binds both VEGFR-1 and VEGFR-2.	FLT1 KDR	4.23e-06	2	72	2	17325350
Pubmed	Phase III Trial of Adjuvant Sunitinib in Patients with High-Risk Renal Cell Carcinoma: Exploratory Pharmacogenomic Analysis.	FLT1 KDR	4.23e-06	2	72	2	30401688
Pubmed	Engraftment and reconstitution of hematopoiesis is dependent on VEGFR2-mediated regeneration of sinusoidal endothelial cells.	FLT1 KDR	4.23e-06	2	72	2	19265665
Pubmed	Toll-like receptor 2 and nucleotide-binding oligomerization domain-2 play divergent roles in the recognition of gut-derived lactobacilli and bifidobacteria in dendritic cells.	TLR2 NOD2	4.23e-06	2	72	2	18217947
Pubmed	VEGF receptor phosphorylation status and apoptosis is modulated by a green tea component, epigallocatechin-3-gallate (EGCG), in B-cell chronic lymphocytic leukemia.	FLT1 KDR	4.23e-06	2	72	2	14996703
Pubmed	Distinct roles of VEGFR-1 and VEGFR-2 in the aberrant hematopoiesis associated with elevated levels of VEGF.	FLT1 KDR	4.23e-06	2	72	2	17376891
Pubmed	Vascular endothelial growth factor and its soluble receptors VEGFR-1 and VEGFR-2 in the serum of patients with systemic lupus erythematosus.	FLT1 KDR	4.23e-06	2	72	2	14760936
Pubmed	DC electric stimulation upregulates angiogenic factors in endothelial cells through activation of VEGF receptors.	FLT1 KDR	4.23e-06	2	72	2	21524919
Pubmed	VEGFR1 and VEGFR2 involvement in extracellular galectin-1- and galectin-3-induced angiogenesis.	FLT1 KDR	4.23e-06	2	72	2	23799140
Pubmed	VEGFR2-mediated vascular dilation as a mechanism of VEGF-induced anemia and bone marrow cell mobilization.	FLT1 KDR	4.23e-06	2	72	2	25310988
Pubmed	Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.	FLT1 KDR	4.23e-06	2	72	2	15592523
Pubmed	The Staphylococcus aureus lipoprotein SitC colocalizes with Toll-like receptor 2 (TLR2) in murine keratinocytes and elicits intracellular TLR2 accumulation.	TLR2 NOD2	4.23e-06	2	72	2	20679445
Pubmed	Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling.	TLR2 NOD2	4.23e-06	2	72	2	21245149
Pubmed	Identification of functional VEGF receptors on human platelets.	FLT1 KDR	4.23e-06	2	72	2	11852061
Pubmed	Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies.	FLT1 KDR	4.23e-06	2	72	2	9973224
Pubmed	Distinct roles of vascular endothelial growth factor receptor-1- and receptor-2-mediated signaling in T cell priming and Th17 polarization to lipopolysaccharide-containing allergens in the lung.	FLT1 KDR	4.23e-06	2	72	2	20921519
Pubmed	TLR2 and Nod2 mediate resistance or susceptibility to fatal intracellular Ehrlichia infection in murine models of ehrlichiosis.	TLR2 NOD2	4.23e-06	2	72	2	23526993
Pubmed	Nucleotide-binding oligomerization domain protein 2-deficient mice control infection with Mycobacterium tuberculosis.	TLR2 NOD2	4.23e-06	2	72	2	17709422
Pubmed	Prognostic significance of VEGF receptors expression on the tumor cells in skull base chordoma.	FLT1 KDR	4.23e-06	2	72	2	31240525
Pubmed	The Prognostic Value of the Combination of Low VEGFR-1 and High VEGFR-2 Expression in Endothelial Cells of Colorectal Cancer.	FLT1 KDR	4.23e-06	2	72	2	30423986
Pubmed	Properties of two VEGF receptors, Flt-1 and KDR, in signal transduction.	FLT1 KDR	4.23e-06	2	72	2	10865839
Pubmed	Retinal astrocytes pretreated with NOD2 and TLR2 ligands activate uveitogenic T cells.	TLR2 NOD2	4.23e-06	2	72	2	22808176
Pubmed	Inhibition of Vascular Endothelial Growth Factor Receptors 1 and 2 Attenuates Natural Killer Cell and Innate Immune Responses in an Experimental Model for Obliterative Bronchiolitis.	FLT1 KDR	4.23e-06	2	72	2	34774518
Pubmed	Attenuation of VEGFR-2 expression by sFlt-1 and low oxygen in human placenta.	FLT1 KDR	4.23e-06	2	72	2	24260556
Pubmed	Erk5 null mice display multiple extraembryonic vascular and embryonic cardiovascular defects.	FLT1 KDR HBB	6.79e-06	18	72	3	12093914
Pubmed	Hypoxia-inducible factor-1 deficiency results in dysregulated erythropoiesis signaling and iron homeostasis in mouse development.	FLT1 KDR HBB	8.05e-06	19	72	3	16787915
Pubmed	MARCO is required for TLR2- and Nod2-mediated responses to Streptococcus pneumoniae and clearance of pneumococcal colonization in the murine nasopharynx.	TLR2 NOD2	1.27e-05	3	72	2	23197261
Pubmed	Early endocardial morphogenesis requires Scl/Tal1.	FLT1 KDR	1.27e-05	3	72	2	17722983
Pubmed	The expression of VEGF receptor genes is concurrently influenced by epigenetic gene silencing of the genes and VEGF activation.	FLT1 KDR	1.27e-05	3	72	2	19633424
Pubmed	Analysis of circulating vascular endothelial growth factor and its soluble receptors in patients with different forms of chronic urticaria.	FLT1 KDR	1.27e-05	3	72	2	25756047
Pubmed	Vascular endothelial growth factor isoform and receptor expression during compensatory lung growth.	FLT1 KDR	1.27e-05	3	72	2	19535097
GeneFamily	Receptor Tyrosine Kinases\|CD molecules	FLT1 KDR FGFR4	1.43e-04	40	46	3	321
GeneFamily	Myosin heavy chains	MYH3 MYH8	6.51e-04	15	46	2	1098
GeneFamily	WD repeat domain containing\|Caspase recruitment domain containing\|Apoptosome	APAF1 NOD2	2.63e-03	30	46	2	959
GeneFamily	Ankyrin repeat domain containing	ASB18 KANK4 TNKS ANKRD55	3.29e-03	242	46	4	403
ToppCell	facs-MAT-Fat-18m-Endothelial\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KANK4 KDR PRAG1 ITPRIPL1	6.50e-07	190	72	6	34e56c5e7ea6a8f227dbaefe73cbb8818d18b523
ToppCell	facs-MAT-Fat-18m-Endothelial-nan\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KANK4 KDR PRAG1 ITPRIPL1	6.50e-07	190	72	6	14cdb660ad3aabcf49572173e7628d8b99dcbe6f
ToppCell	facs-MAT-Fat-18m-Endothelial-endothelial_cell\|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KANK4 KDR PRAG1 ITPRIPL1	6.50e-07	190	72	6	9aaa48f3aad813c87a45efdbb67d255c94f6e6a4
ToppCell	LPS-antiTNF-Endothelial-Endothelial-Vein\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 SPEF2 IL4I1 F5 SH2B2 ADGRG6	6.90e-07	192	72	6	81baf1c4063469bb0c03a8602b40e387ba7b0dfb
ToppCell	(08)_PNEC-(2)_48hpi\|(08)_PNEC / shred by cell type and Timepoint	RHCG CLCN5 ENPP1 OAS3 KDR	3.44e-06	142	72	5	e95d34170f5053678e0dd9793e68d93c03b05822
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	FLT1 SH3TC1 UNC45B KDR ST6GALNAC2	5.12e-06	154	72	5	b0735365de153d4586ca17896431d7bd9c7d8eac
ToppCell	Fetal_brain-organoid_Tanaka_cellReport-GW16-Mesenchymal-Cilia-bearing_cell\|GW16 / Sample Type, Dataset, Time_group, and Cell type.	SPEF2 CRPPA ROM1 METAP1D UBOX5	6.95e-06	164	72	5	346e1530b4bf30adbcb2f7d64fdfb4cd8df69d7f
ToppCell	facs-Trachea-18m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 UNC45B KDR PFKFB3 ST6GALNAC2	9.27e-06	174	72	5	40bb87d219aafab0357ab0d797efd38085fc0312
ToppCell	356C-Lymphocytic-CD4_T-cell-Treg_cell_2\|356C / Donor, Lineage, Cell class and subclass (all cells)	EEF1AKMT3 ROM1 TNRC6C F5 VCPIP1	1.03e-05	178	72	5	8b939659f713eea50a1a6e28b571f680ca0b4c12
ToppCell	mild_COVID-19_(asymptomatic)-cDC\|World / disease group, cell group and cell class (v2)	ASB18 OAS3 IL4I1 ADGRG6 NOD2	1.09e-05	180	72	5	68d1c867734fb2977b01ac686b20bf602f9a6b72
ToppCell	facs-GAT-Fat-24m-Endothelial-nan\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ST6GALNAC2	1.42e-05	190	72	5	da2fcd4a2cc6e45c8174109d892f1424e39919a1
ToppCell	facs-GAT-Fat-24m-Endothelial\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ST6GALNAC2	1.42e-05	190	72	5	3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f
ToppCell	facs-SCAT-Fat-18m-Endothelial-nan\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ITPRIPL1	1.42e-05	190	72	5	b0c9dae8189d407c94964c6bfe3ef92035245357
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PFKFB3 NOD2	1.42e-05	190	72	5	38a815abf0ac5cac6071737cadc54a514f62d37d
ToppCell	facs-SCAT-Fat-18m-Endothelial\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ITPRIPL1	1.42e-05	190	72	5	ee63dc04e91ad49aa7820c98e97261176ecebaa6
ToppCell	facs-GAT-Fat-24m-Endothelial-endothelial_cell\|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ST6GALNAC2	1.42e-05	190	72	5	e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4
ToppCell	facs-SCAT-Fat-18m-Endothelial-endothelial_cell\|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ITPRIPL1	1.42e-05	190	72	5	0e50808bfc3d0820524c8470ae3e8250819d65b2
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PFKFB3 NOD2	1.42e-05	190	72	5	bb1476b44dd49e1dd52a636a91c4600b6d4fbe2e
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb-3m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PFKFB3 NOD2	1.42e-05	190	72	5	d180205c70b5ca9bc5a01a2e6cb42fcebc7f630d
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 UNC45B KDR PFKFB3 NOD2	1.42e-05	190	72	5	2655df8c0883dd811fa7617301f9c4b0a4dd55ec
ToppCell	droplet-Fat-Gat-18m-Endothelial\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ST6GALNAC2	1.49e-05	192	72	5	c312e39003c51503c9f648332fb5c6218f33f99b
ToppCell	droplet-Fat-Gat-18m-Endothelial-Cd36+\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ST6GALNAC2	1.49e-05	192	72	5	df09056f0e562f53b6fb30b674d2d83e9eb857d0
ToppCell	droplet-Fat-Gat-18m-Endothelial-endothelial_cell\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1 ST6GALNAC2	1.49e-05	192	72	5	133b3ad251d72ff31e45e1dc6217945516ac63de
ToppCell	LPS-IL1RA+antiTNF-Endothelial-Endothelial-Vein\|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 IL4I1 F5 SH2B2 ADGRG6	1.53e-05	193	72	5	7261c1ce30c796b61c6ec58e64a051baa24732ff
ToppCell	367C-Myeloid-Dendritic-cDC1\|Dendritic / Donor, Lineage, Cell class and subclass (all cells)	ENPP1 PFKFB3 ITPRIPL1 ADGRG6 VCPIP1	1.61e-05	195	72	5	fca958f73de450ef813444d3dc590353f1c55326
ToppCell	Bronchial-10x5prime-Immune_Myeloid-Macrophage_other-Macro_interstitial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TLR2 OAS3 PFKFB3 IL4I1 NOD2	1.69e-05	197	72	5	1a30747a2188a890f58d831030328986b3a4356d
ToppCell	LPS_anti-TNF-Endothelial-Endothelial-Vein\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	FLT1 IL4I1 F5 SH2B2 ADGRG6	1.77e-05	199	72	5	cfb624c7728046fc7f3ef071f57e4d7b013f3fef
ToppCell	LPS_only-Endothelial-Endothelial-Activated_Alv_Cap\|LPS_only / Treatment groups by lineage, cell group, cell type	FLT1 OAS3 KDR IL4I1 SH2B2	1.81e-05	200	72	5	edb64556b3fefe3144f73b6efe23b9ffd34091d2
ToppCell	facs-Brain_Non-Myeloid-Striatum-24m-Macroglial-astrocyte\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	RHCG CUL9 METAP1D HDAC10	4.74e-05	123	72	4	a45d6907c041ad3f3218cd46dccfc25d4bd961cb
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FLT1 SH3TC1 UNC45B ST6GALNAC2	6.06e-05	131	72	4	308ddb7fe113eac5dbeb9cb0b688d9e09275ce5e
ToppCell	Substantia_nigra-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	FLT1 SH3TC1 UNC45B ST6GALNAC2	6.24e-05	132	72	4	06e7337de35bd7120655a22b6020604ad004c4e1
ToppCell	Frontal_cortex-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Frontal_cortex / BrainAtlas - Mouse McCarroll V32	FLT1 UNC45B ST6GALNAC2 NOD2	6.43e-05	133	72	4	bc29a2faa151b0e48c1c7e3f016cccc49f9a15eb
ToppCell	356C-Fibroblasts-Fibroblast-E\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FCSK SH3TC1 CRPPA HDAC10	7.01e-05	136	72	4	edfd453c9a650d69d05a5a3ab15f7df56349fa86
ToppCell	356C-Fibroblasts-Fibroblast-E-\|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells)	FCSK SH3TC1 CRPPA HDAC10	7.01e-05	136	72	4	03e4e2353c23ceffde35b2d0aadd15299e3db09f
ToppCell	TCGA-Uterus-Primary_Tumor-Uterine_Carcinoma-Uterine_Carcinosarcoma_Heterologous_Type-4\|TCGA-Uterus / Sample_Type by Project: Shred V9	MYH3 MYH8 FBXO10 UNC45B	7.41e-05	138	72	4	d1104a9f751ffa6970fd3096a4abf5bed30aa78f
ToppCell	Posterior_cortex-Endothelial-ENDOTHELIAL_STALK\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	FLT1 SH3TC1 UNC45B ST6GALNAC2	8.51e-05	143	72	4	35d3652680c4dddd293301595d813161c66e5673
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK-Flt1_1\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FLT1 SH3TC1 UNC45B ST6GALNAC2	8.74e-05	144	72	4	1c118b22c2ff3a526a5207d6c9d772636ee065fd
ToppCell	TCGA-Uterus\|World / Sample_Type by Project: Shred V9	MYH3 MYH8 UNC45B KANK4	8.74e-05	144	72	4	7efb45286ebf2dbfb9125fd6373f28dccb029a2e
ToppCell	Globus_pallidus-Endothelial-ENDOTHELIAL_STALK\|Globus_pallidus / BrainAtlas - Mouse McCarroll V32	FLT1 SH3TC1 UNC45B ST6GALNAC2	9.98e-05	149	72	4	d9c47f523c75ddcd6131e45d2ffc24b970932cae
ToppCell	10x3'2.3-week_12-13-Hematopoietic-HSC/MPP_and_pro-eo/baso/mast_precursor\|week_12-13 / cell types per 3 fetal stages;per 3',per 5'	MYH3 CRPPA TTC34 SLC27A2	9.98e-05	149	72	4	797b5f267e86fbe1d7af99df514d8074446603c6
ToppCell	saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23\|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ENPP1 DHDDS KDR TNRC6C	1.08e-04	152	72	4	0652ee3443e6fbb679d2c4f326239ae7c803f924
ToppCell	5'-Adult-Appendix-Epithelial-Tuft-related-BEST4+_epithelial\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RHCG ABCC3 CRPPA SLC27A2	1.16e-04	155	72	4	5fabe24a784f0be46040ffc886eabd8d5ce78121
ToppCell	Thalamus-Endothelial-ENDOTHELIAL_STALK\|Thalamus / BrainAtlas - Mouse McCarroll V32	FLT1 SH3TC1 UNC45B ST6GALNAC2	1.16e-04	155	72	4	fe6c4aba0e98cda84bf178aeac2e9fa834477f22
ToppCell	facs-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 UNC45B KDR FAM187A	1.25e-04	158	72	4	78b48b110b777bcc4c07cd23388bee911c0231d6
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TLR2 PFKFB3 F5 NOD2	1.31e-04	160	72	4	3b5a335786165391fe983ff0585cd508733793aa
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Myeloid-Granulocytic-Neutrophil\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	TLR2 PFKFB3 F5 NOD2	1.31e-04	160	72	4	2586035a1380bc56814a6db0ca773ad835666042
ToppCell	Entopeduncular-Endothelial-ENDOTHELIAL_STALK\|Entopeduncular / BrainAtlas - Mouse McCarroll V32	SH3TC1 UNC45B ITPRIPL1 ST6GALNAC2	1.31e-04	160	72	4	04714d0b9bad4c11fa193ed168e2d84a4df39e2e
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UNC45B KDR ST6GALNAC2	1.34e-04	161	72	4	a60ef3f390f56bb05b687b17986fe6382f69f260
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell-Endo\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UNC45B KDR ST6GALNAC2	1.38e-04	162	72	4	0bdb1e5ba33e162bec1acb28256c1405a7658ee5
ToppCell	10x5'-GI_large-bowel-Lymphocytic_T_CD4-Tregs\|GI_large-bowel / Manually curated celltypes from each tissue	THADA SH3TC1 F5 ANKRD55	1.38e-04	162	72	4	9a5e65c45f73a6a685b8362aa2e6aea77181caa3
ToppCell	T_cells-Tph_and_Tfh\|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FLT1 THADA ANKRD55 SLC27A2	1.38e-04	162	72	4	146058f2d60846376078916055d08f68562e3a7c
ToppCell	primary_visual_cortex-Non-neuronal-endothelial_cell\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UNC45B KDR ST6GALNAC2	1.38e-04	162	72	4	5799a602ef8d83925907e8e34532428be7330228
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UNC45B KDR ST6GALNAC2	1.44e-04	164	72	4	6a41a159134e605b80d5e731f9ed5bc803bb531b
ToppCell	facs-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l32-30\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	RHCG SPEF2 KANK4 SLC27A2	1.44e-04	164	72	4	3caf4cdaa0164907893fea61e251fd8b5fa926e4
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UNC45B KDR ST6GALNAC2	1.44e-04	164	72	4	ec68954fc09b6850273b5e59caa6b09d02151097
ToppCell	renal_papilla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_2\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ASB18 MYH8 ENPP1 PRAG1	1.44e-04	164	72	4	382e42701779d12a7948690b3be72d06dd75c8b4
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MTHFD2L OAS3 MTX1 NOD2	1.48e-04	165	72	4	436ce4bc75e1ba4351c439ccad19f84ad5bcb92f
ToppCell	saliva-Severe-critical_progression_d12-22_with-steroid-Myeloid-Macrophage-macrophage,_alveolar\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MTHFD2L OAS3 MTX1 NOD2	1.48e-04	165	72	4	242bdb7654f415391fb8e9bdc06412c7eee9c97e
ToppCell	Fetal_29-31_weeks-Immune-dendritic_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	SH3TC1 ENPP1 LRRK1 IL4I1	1.48e-04	165	72	4	d8b0a9b6f704b98e8f0412c11739879a26c036e2
ToppCell	frontal_cortex-Non-neuronal-endothelial_cell-Endo-Endo_Ctla2a\|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	FLT1 UNC45B KDR ST6GALNAC2	1.51e-04	166	72	4	27af6c906cff1d40d134f0386db7708869691121
ToppCell	droplet-Thymus-nan-3m-Myeloid-B_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FCSK IL4I1 SH2B2 ADCY9	1.51e-04	166	72	4	c0af93db981dfd448abc7efcd257f3e5ff066aae
ToppCell	CTRL-Myeloid-Monocyte\|CTRL / Disease state, Lineage and Cell class	FLT1 TLR2 PFKFB3 F5	1.58e-04	168	72	4	13dca90c7b811e4d5e8fa44f5e892e29be9787a6
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-double_negative_T_cell\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SHPRH CSTF1 ADCY9 TRPT1	1.58e-04	168	72	4	de1042267407719f19eb3f580a5df0c9cd0e8273
ToppCell	CTRL-Myeloid-Monocyte\|Myeloid / Disease state, Lineage and Cell class	FLT1 TLR2 PFKFB3 F5	1.69e-04	171	72	4	bfa01571516a0b24476ae06cb07f56c5579dbd70
ToppCell	facs-Trachea-24m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l10\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 UNC45B KDR PFKFB3	1.73e-04	172	72	4	c84cab89c97d647b8a256fd08e33d9102810febd
ToppCell	Control-MAIT\|Control / Disease group and Cell class	ABCC3 FLT1 SPEF2 TTC34	1.73e-04	172	72	4	552bc62e8e8bb0ac1cd0452f4410a3af087787eb
ToppCell	tumor_Lymph_Node_/_Brain-Myeloid_cells-Pleural_Mac\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	SH3TC1 ZFYVE26 IL4I1 SH2B2	1.77e-04	173	72	4	8384d533a1071fc65a06e6d9f5f17d8ab00c3966
ToppCell	droplet-Heart-4Chambers-18m-Endothelial\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 SH3TC1 UNC45B KDR	1.77e-04	173	72	4	9a04271c51fae34f547db3206f9ff5857686e45c
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-nan\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR SLC27A2	1.81e-04	174	72	4	fa6eb451555766398996bbe8f555a3f4c0f3c108
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Endothelial\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR SLC27A2	1.81e-04	174	72	4	1f5b0fa58b2a7335667357af7e50e5242cd13d7d
ToppCell	facs-Mammary_Gland-Mammary_Gland-21m-Endothelial-endothelial_cell\|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR SLC27A2	1.81e-04	174	72	4	ac3aee6ed49d1c421f33509e3ffc5cb17750a473
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_mature\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT1 UNC45B KDR ADGRG6	1.85e-04	175	72	4	2e54961846c65b185d9bd6e305dd81205579d890
ToppCell	E18.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	FLT1 UNC45B KDR ADGRG6	1.85e-04	175	72	4	efa6a05f7417d46141b6e635f258c126b7a03aa1
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l7\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 UNC45B KDR ST6GALNAC2	1.85e-04	175	72	4	7be76d39e1a4f4ac709672cd2d409a2523a083ce
ToppCell	T_cells-Tph_and_Tfh\|T_cells / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues	FLT1 THADA F5 SLC27A2	1.89e-04	176	72	4	56c055488e34605d32562571a2fee621b47c9441
ToppCell	facs-Aorta\|facs / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 MYH8 UNC45B KDR	1.89e-04	176	72	4	0b3491451be02c18a16cdb875645be47eb867a7f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Endothelial-blood_vessel_endothelial_cell_of_kidney-capillary-immature_endothelial_cell-Glomerular_Capillary_Endothelial_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	FLT1 LDHAL6A KDR ANKRD55	1.89e-04	176	72	4	64e426f5e84884ce2c29acf6f4b958962a63927f
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))-\|Thalamus / BrainAtlas - Mouse McCarroll V32	RHCG MYH8 EEF1AKMT3	1.91e-04	69	72	3	10d5fccc1fa10ffc9051df42dd0e5046d97ec4af
ToppCell	Thalamus-Neuronal-Excitatory-eN2(Slc17a7_Slc17a6)-Slc17a6-Excitatory_Neuron.Slc17a6.Pitx2_(Subthalamic_nucleus_(STN))\|Thalamus / BrainAtlas - Mouse McCarroll V32	RHCG MYH8 EEF1AKMT3	1.91e-04	69	72	3	9d7e911434c6b18327fa7adaec5c449e0c300919
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PFKFB3	1.93e-04	177	72	4	ca5a30b3e7bcfdd8de01ceaf7449735b5cd503af
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PFKFB3	1.93e-04	177	72	4	f471f7747d6e8db7546899019af9508f48a14f89
ToppCell	368C-Lymphocytic-NK_cells-NK_cell_E\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	PIK3R4 ENPP1 OAS3 METAP1D	1.93e-04	177	72	4	946803293a7955116c80f403e99e4093e798ca3f
ToppCell	droplet-Limb_Muscle-MUSCLE-30m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PFKFB3	1.93e-04	177	72	4	cd0684b876c2a7d5fe7e2773e8e25bb61ecbc795
ToppCell	5'-Adult-Appendix-Hematopoietic-Myeloid-cDC1\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	LRRK1 IL4I1 ITPRIPL1 NOD2	1.93e-04	177	72	4	345cebc19f93970a9a46be139208b300081f5493
ToppCell	droplet-Bladder-BLADDER-1m-Endothelial-nan\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KANK4 KDR	1.98e-04	178	72	4	6bef4ef48f649c6e38ae732bc08e6d7814db588b
ToppCell	ASK440-Epithelial-Transformed_epithelium\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	FLT1 SHPRH PFKFB3 TARS2	1.98e-04	178	72	4	86f1741636ed3e85bb4a65f84949b718fc38c290
ToppCell	droplet-Lung-LUNG-30m-Endothelial-Artery_endothelial_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B ST6GALNAC2 ADGRG6	2.02e-04	179	72	4	a09647750eba9d93c5efc1db3b555fefb5eec7b5
ToppCell	droplet-Fat-Gat-18m-Endothelial-nan\|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR PRAG1	2.02e-04	179	72	4	08cf9986804a6417a9afb19b50c69a3554f71ec6
ToppCell	CV-Severe-4\|Severe / Virus stimulation, Condition and Cluster	TTC34 F5 SLC27A2 TRPT1	2.06e-04	180	72	4	cf84a01e6a33e5d27ad7be1d9069a0370b5116d1
ToppCell	droplet-Trachea-3m-Mesenchymal-myofibroblast-tracheobronchial_smooth_muscle_cell-smooth_muscle_cell_of_trachea_l6-17\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 SH3TC1 KDR ITPRIPL1	2.06e-04	180	72	4	455d1e3ccf2ab609954f3b870e8f514ddca735f4
ToppCell	(01)_Cycling_Basal_(homeostasis)-(1)_24hpi\|(01)_Cycling_Basal_(homeostasis) / shred by cell type and Timepoint	ADCY9 ADGRG6 NOD2	2.08e-04	71	72	3	6aa56b0daaeb5e0ae30619f9c6945c8e42899b27
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B APAF1 KDR	2.11e-04	181	72	4	4df7972f88117108698efd06b124b232f8588981
ToppCell	Control-Myeloid-DC1\|Control / Condition, Lineage and Cell class	ENPP1 LRRK1 ITPRIPL1 ADGRG6	2.11e-04	181	72	4	5a2a1f017ad23baed9972c68b4a46f4c618ef21a
ToppCell	droplet-Liver-hepatocytes-3m-Endothelial\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B APAF1 KDR	2.11e-04	181	72	4	cbb530566893281289026bfd93adf721decd4ca3
ToppCell	droplet-Trachea-3m-Endothelial-endothelial_cell_of_trachea-tracheal_endothelial_cell-tracheal_endothelial_cell_l19\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	FLT1 UNC45B KDR NOD2	2.15e-04	182	72	4	840427d1c23d60482c943ff006b14007ed44d247
ToppCell	droplet-Kidney-nan-3m-Endothelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KANK4 KDR	2.15e-04	182	72	4	f4a5f1c3a04c0566eb96607dab7a0d9a5ebc3fd1
ToppCell	facs-Liver-Hepatocytes-24m\|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ABCC3 ENPP1 FGFR4 F5	2.20e-04	183	72	4	d0721c6aa426953a520d40e976b6e65aa7ca65e8
ToppCell	LPS-IL1RA\|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 KDR IL4I1 SH2B2	2.24e-04	184	72	4	c066c2ec4f0f1d6eb183fca5c7bb0cd45c9950dc
ToppCell	facs-Limb_Muscle-Muscle_forelimb_and_hindlimb-18m-Endothelial-endothelial_cell\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FLT1 UNC45B KDR ITPRIPL1	2.29e-04	185	72	4	c3105978d971da7d0fad1a717ee29afee5ed6357
ToppCell	LPS-IL1RA-Endothelial-Endothelial-Activated_Gen_Cap\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	FLT1 KDR IL4I1 SH2B2	2.29e-04	185	72	4	808d5e880069aff8866cd2c733b9fe568a37701f
Disease	cerebral cavernous malformation (is_marker_for)	FLT1 KDR	1.52e-05	3	67	2	DOID:0060669 (is_marker_for)
Disease	allergic contact dermatitis (is_marker_for)	FLT1 KDR	1.52e-05	3	67	2	DOID:3042 (is_marker_for)
Disease	arteriovenous malformations of the brain (is_marker_for)	FLT1 KDR	1.52e-05	3	67	2	DOID:0060688 (is_marker_for)
Disease	meningococcal meningitis (is_implicated_in)	TLR2 NOD2	3.04e-05	4	67	2	DOID:0080176 (is_implicated_in)
Disease	latent autoimmune diabetes in adults	THADA PFKFB3	3.04e-05	4	67	2	EFO_0009706
Disease	Hypophosphatemic rickets	CLCN5 ENPP1	5.06e-05	5	67	2	cv:C1704375
Disease	Hereditary hypophosphatemic rickets	CLCN5 ENPP1	5.06e-05	5	67	2	cv:CN296404
Disease	Rickets	CLCN5 ENPP1	5.06e-05	5	67	2	cv:C0035579
Disease	rheumatoid arthritis, ACPA-negative rheumatoid arthritis	TYK2 ANKRD55	5.06e-05	5	67	2	EFO_0000685, EFO_0009460
Disease	torsin-1A-interacting protein 1 measurement	SARM1 F5	7.57e-05	6	67	2	EFO_0802137
Disease	osteopetrosis (implicated_via_orthology)	CLCN5 LRRK1	1.06e-04	7	67	2	DOID:13533 (implicated_via_orthology)
Disease	X-16935 measurement	ABCC3 SLC27A2	1.06e-04	7	67	2	EFO_0800763
Disease	colitis (biomarker_via_orthology)	SI KDR NOD2	1.21e-04	42	67	3	DOID:0060180 (biomarker_via_orthology)
Disease	nasopharynx carcinoma (is_marker_for)	FLT1 KDR FGFR4	1.29e-04	43	67	3	DOID:9261 (is_marker_for)
Disease	psoriasis (is_marker_for)	FLT1 TLR2 KDR	1.39e-04	44	67	3	DOID:8893 (is_marker_for)
Disease	leprosy (is_implicated_in)	TLR2 NOD2	1.41e-04	8	67	2	DOID:1024 (is_implicated_in)
Disease	E3 ubiquitin-protein ligase RNF13 measurement	SARM1 F5	1.41e-04	8	67	2	EFO_0801556
Disease	Distal arthrogryposis	MYH3 MYH8	1.81e-04	9	67	2	cv:C0265213
Disease	interferon alpha/beta receptor 1 measurement	TYK2 SARM1	1.81e-04	9	67	2	EFO_0021850
Disease	autosomal dominant hyaline body myopathy (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:0111269 (implicated_via_orthology)
Disease	distal arthrogryposis type 2B3 (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:0111602 (implicated_via_orthology)
Disease	distal arthrogryposis type 1 (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:0111596 (implicated_via_orthology)
Disease	dilated cardiomyopathy 1S (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:0110454 (implicated_via_orthology)
Disease	congenital myopathy 6 (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:0080719 (implicated_via_orthology)
Disease	inclusion body myositis (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:3429 (implicated_via_orthology)
Disease	distal arthrogryposis type 2A (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:0111605 (implicated_via_orthology)
Disease	familial hypertrophic cardiomyopathy (implicated_via_orthology)	MYH3 MYH8	2.26e-04	10	67	2	DOID:0080326 (implicated_via_orthology)
Disease	Antithrombotic agent use measurement	FLT1 TNKS F5	2.70e-04	55	67	3	EFO_0009925
Disease	retinopathy of prematurity (biomarker_via_orthology)	FLT1 KDR	3.30e-04	12	67	2	DOID:13025 (biomarker_via_orthology)
Disease	distal myopathy (implicated_via_orthology)	MYH3 MYH8	3.30e-04	12	67	2	DOID:11720 (implicated_via_orthology)
Disease	myotonia congenita (implicated_via_orthology)	MYH3 MYH8	3.30e-04	12	67	2	DOID:2106 (implicated_via_orthology)
Disease	thyroid gland carcinoma (is_marker_for)	FLT1 KDR	3.30e-04	12	67	2	DOID:3963 (is_marker_for)
Disease	macular retinal edema (is_marker_for)	FLT1 KDR	3.30e-04	12	67	2	DOID:4449 (is_marker_for)
Disease	Conventional (Clear Cell) Renal Cell Carcinoma	DNHD1 FLT1 APAF1 KDR	3.64e-04	148	67	4	C0279702
Disease	restrictive cardiomyopathy (implicated_via_orthology)	MYH3 MYH8	3.90e-04	13	67	2	DOID:397 (implicated_via_orthology)
Disease	T-cell surface glycoprotein CD3 epsilon chain measurement	SARM1 F5	3.90e-04	13	67	2	EFO_0802114
Disease	rheumatoid arthritis, ACPA-positive rheumatoid arthritis, rheumatoid factor seropositivity measurement	TYK2 TTC34 ANKRD55	4.03e-04	63	67	3	EFO_0000685, EFO_0007791, EFO_0009459
Disease	Kuhnt-Junius degeneration (is_marker_for)	FLT1 TLR2	4.54e-04	14	67	2	DOID:10873 (is_marker_for)
Disease	Crohn's disease	TYK2 THADA KANK4 GSAP ANKRD55 NOD2	4.98e-04	441	67	6	EFO_0000384
Disease	distal arthrogryposis (implicated_via_orthology)	MYH3 MYH8	5.23e-04	15	67	2	DOID:0050646 (implicated_via_orthology)
Disease	inflammatory bowel disease	TYK2 THADA DHDDS F5 ANKRD55 NOD2	5.47e-04	449	67	6	EFO_0003767
Disease	Spondyloepiphyseal Dysplasia	FLT1 KDR	5.97e-04	16	67	2	C0038015
Disease	Spondyloepiphyseal Dysplasia Tarda, X-Linked	FLT1 KDR	5.97e-04	16	67	2	C3541456
Disease	Schwartz-Jampel Syndrome, Type 1	FLT1 KDR	5.97e-04	16	67	2	C4551479
Disease	Schwartz-Jampel Syndrome	FLT1 KDR	5.97e-04	16	67	2	C0036391
Disease	Melnick-Needles Syndrome	FLT1 KDR	5.97e-04	16	67	2	C0025237
Disease	blood phosphate measurement	ENPP1 FGFR4 PRAG1 ADCY9	6.70e-04	174	67	4	EFO_0010972
Disease	Rheumatoid Arthritis	TYK2 ABCC3 TLR2 ANKRD55	6.70e-04	174	67	4	C0003873
Disease	allergic rhinitis (is_marker_for)	TLR2 NOD2	6.76e-04	17	67	2	DOID:4481 (is_marker_for)
Disease	Eye Abnormalities	APAF1 CRPPA	6.76e-04	17	67	2	C0015393
Disease	Kuhnt-Junius degeneration (is_implicated_in)	FLT1 KDR	6.76e-04	17	67	2	DOID:10873 (is_implicated_in)
Disease	Uremia	FLT1 KDR	6.76e-04	17	67	2	C0041948
Disease	Van Buchem disease	FLT1 KDR	6.76e-04	17	67	2	C0432272
Disease	Hemangiosarcoma	FLT1 KDR	7.59e-04	18	67	2	C0018923
Disease	Osteochondrodysplasias	FLT1 KDR	8.47e-04	19	67	2	C0029422
Disease	kidney failure (biomarker_via_orthology)	RHCG TLR2	8.47e-04	19	67	2	DOID:1074 (biomarker_via_orthology)
Disease	Dyschondroplasias	FLT1 KDR	8.47e-04	19	67	2	C0013366
Disease	urinary microalbumin measurement	MON2 CRPPA	9.40e-04	20	67	2	EFO_0010967
Disease	Multiple Epiphyseal Dysplasia	FLT1 KDR	9.40e-04	20	67	2	C0026760
Disease	Deep Vein Thrombosis	KDR F5	1.04e-03	21	67	2	C0149871
Disease	Venous Thrombosis	KDR F5	1.04e-03	21	67	2	C0042487
Disease	pre-eclampsia (is_implicated_in)	FLT1 F5	1.47e-03	25	67	2	DOID:10591 (is_implicated_in)
Disease	Cerebral Hemorrhage	FLT1 KDR	1.85e-03	28	67	2	C2937358
Disease	respiratory failure, COVID-19	TYK2 OAS3	1.98e-03	29	67	2	EFO_0009686, MONDO_0100096
Disease	rhinitis (is_implicated_in)	TLR2 NOD2	2.12e-03	30	67	2	DOID:4483 (is_implicated_in)
Disease	obesity	TNKS PFKFB3 PRAG1 ADCY9	2.22e-03	241	67	4	EFO_0001073

Protein segments in the cluster

Peptide	Gene	Start	Entry
LLLPLHELRGHNGCV	APAF1	1116	O14727
GLRLHTVNVRQLGHC	ADGRG6	511	Q86SQ4
LILCNQIHHGLRSGI	FBXO10	521	Q9UK96
LIGRHKNIINLLGVC	FGFR4	526	P22455
LLLGTLQHLCRPHGT	EEF1AKMT3	161	Q96AZ1
GNRILCSIILSHHQG	ANKRD55	206	Q3KP44
FHQQRLGHGLIISCP	FAM187A	276	A6NFU0
NGLHLHNLRGLLCAL	DNHD1	1921	Q96M86
GRVASLLEHHALQLC	CCDC22	201	O60826
LLEHHALQLCQQTGR	CCDC22	206	O60826
GHAGRHLQQIILDQC	CRPPA	321	A4D126
GGIQAARVLHQALLH	ABCC3	1036	O15438
GLHQACQLARHVLLL	METAP1D	96	Q6UB28
LHALQHPCIVALIGI	LRRK1	1311	Q38SD2
LGGHTACVRLLLQHR	ASB18	161	Q6ZVZ8
LVLHQLRCNGVLEGI	MYH8	691	P13535
LCRHGENEHNLQGRI	PFKFB3	251	Q16875
NLHRCLNLILISDHG	ENPP1	411	P22413
RTLLNLAHCHGAVLG	MON2	681	Q7Z3U7
SHQHRLGLGVRALNL	PORCN	386	Q9H237
LGRGLQQRSLHHFLI	ITPRIPL1	481	Q6GPH6
NLGLITLIGLNSHLH	OR8B12	41	Q8NGG6
VQLGPGSVLQHCHLQ	FCSK	376	Q8N0W3
LHTILGVQCLPLHNL	GSAP	701	A4D1B5
LQELHRHGLGNLLLS	C4orf50	96	Q6ZRC1
HGAQRLLCVALGQLD	HDAC10	501	Q969S8
LLQGLNLLRQHHELC	KLHL28	21	Q9NXS3
LGLRQCLVTHNGRLL	CLCN5	776	P51795
LLSRGLLHGCIHAIG	ADCY9	281	O60503
ACHHGNVDLVRLLLA	KANK4	936	Q5T7N3
LLLCNHHTLGDQIIT	CUL9	876	Q8IWT3
LLGNVLVCVLAHHFG	HBB	106	P68871
LLSLGHNNIVRCIVH	CSTF1	391	Q05048
LQKHGVCIRVLGDLH	DHDDS	111	Q86SQ9
GLRTVLGLIQQHQHL	OAS3	251	Q9Y6K5
HRILHKLCQGLGLNL	IL4I1	121	Q96RQ9
SGKLQVHLRGLHNLC	MTX1	366	Q13505
LVDLCQGPHLRHTGQ	TARS2	236	Q9BW92
FLLQHSIPGCHLLGR	UBOX5	331	O94941
PSNNCILGHILHRLA	SPEF2	526	Q9C093
IHQHCQVRIDTLGLL	THADA	631	Q6YHU6
RTLCLQHGPLITFHL	TNRC6C	1531	Q9HCJ0
VRLHLLNIGGSQDIH	F5	1826	P12259
HDHLGLRQGDCVALL	SLC27A2	96	O14975
QQHLLLPLGRLHALC	PRORY	116	Q9H606
GKGQACRHLLHLAIQ	ST6GALNAC2	61	Q9UJ37
RQLVCALNGLAGIHI	SHPRH	1021	Q149N8
CGRDFTHVLLQLGHL	SH3TC1	941	Q8TE82
THVLLQLGHLCTRQG	SH3TC1	946	Q8TE82
EHSLVLHQLRCNGVL	MYH3	686	P11055
INLHVRGGHILPCQE	SI	1681	P14410
LLKGLSCQGRTHIHL	TRPT1	141	Q86TN4
IRKDLGNIIHNLCGH	PIK3R4	346	Q99570
LCLHDQLSVQHRGLV	UNC45B	856	Q8IWX7
RLLQETSALHGLCHL	NOD2	471	Q9HC29
LLCSGHLLVQLRHLG	ROM1	36	Q03395
QQLLEDCGIHLGVHR	SARM1	521	Q6SZW1
HRAALAGHLQTCRLL	TNKS	596	O95271
SLLHLSRLCVRHNLG	SPSB2	226	Q99619
HLRLSLNGHGQCHVQ	SH2B2	466	O14492
GLRNIHIFGLANVLH	VCPIP1	286	Q96JH7
LLQLCNGLEHLKEHG	PRAG1	1126	Q86YV5
FHIINIGRLCLDQHS	MTHFD2L	171	Q9H903
RLHIQDTCGINNLHG	RHCG	331	Q9UBD6
LKCGLIQHQLIHSGA	ZNF416	421	Q9BWM5
ARGLLLIQHQRIHTG	ZNF420	541	Q8TAQ5
HIGHHLNVVNLLGAC	KDR	891	P35968
GHHLNVVNLLGACTK	FLT1	886	P17948
LIHLCLLHLRASGQP	VSIG10L2	16	P0DP72
LILLTGVLCHRFHGL	TLR2	601	O60603
RQLLQGHCHARALAI	TTC34	131	A8MYJ7
LNLHRDSIACGHQLI	ZFYVE26	1941	Q68DK2
VHGNVCGRNILLARL	TYK2	731	P29597
QRLGIHSESCHGLIL	LDHAL6A	176	Q6ZMR3